Genetic services survey-experience of people with rare diseases and their families accessing genetic services in the Irish Republic.
Genetic services
Genetic testing
Genomic mainstreaming
Patient experience
Journal
Journal of community genetics
ISSN: 1868-310X
Titre abrégé: J Community Genet
Pays: Germany
ID NLM: 101551501
Informations de publication
Date de publication:
26 Aug 2023
26 Aug 2023
Historique:
received:
19
05
2023
accepted:
15
08
2023
medline:
27
8
2023
pubmed:
27
8
2023
entrez:
26
8
2023
Statut:
aheadofprint
Résumé
Irish Health Service objectives state that patients with rare diseases should have timely access to genomic diagnostics with appropriate pre and post-test counselling. However, waiting times for clinical genetics outpatient appointments, during the study period, were up to two years as staffing levels remain low. A targeted public online survey was conducted in January 2022 to capture the experiences of Rare Disease families trying to access genetic testing and clinical genetic clinics in the Irish Republic. Irish patients experience significant waiting times to access clinical genetic services and self-report anxiety and stress, related to delayed access to diagnosis, clarity around recurrence risk and follow-up management. This negatively impacts personal decisions around family planning, education and employment and has a significant impact on family members seeking clarity on their own risk. Mainstream genetic testing activity is significant. Families report concern over the competency of health care professionals arranging and delivering genetic results and delays in accessing clinical genetics expertise to take them through the clinical implications. Timely access to clinical genetics expertise is important to ensure families with rare diseases have an appropriate understanding of the medical and reproductive implications of a genetic diagnosis and access to relevant care pathways. A national framework to develop competency in genomic literacy for health-care professionals including a national genetic test directory may be beneficial. Clinical genetics teams require ongoing support and investment to ensure the delivery of a safe and effective service for Irish families with rare diseases.
Identifiants
pubmed: 37632685
doi: 10.1007/s12687-023-00664-w
pii: 10.1007/s12687-023-00664-w
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2023. The Author(s).
Références
Bartley N, Napier C, Best M, Butow P (2020) Patient experience of uncertainty in cancer genomics: a systematic review. Genet Med 22(9):1450–1460. https://doi.org/10.1038/s41436-020-0829-y
doi: 10.1038/s41436-020-0829-y
pubmed: 32424175
pmcid: 7462749
Bradley L, Lynch SA (2021) Dying to see you? Deaths on a clinical genetic waiting list in the Republic of Ireland; what are the consequences? J Community Genet 12(1):121–127. https://doi.org/10.1007/s12687-020-00491-3
doi: 10.1007/s12687-020-00491-3
pubmed: 33119819
Central Statistics Office (2021) Statistical yearbook of Ireland 2021. In: Demography – CSO – Central Statistics Office Accessed 17 April 2023
Central Statistics Office (2022) Census of population 2022. In: Introduction - CSO - Central Statistics Office Accessed 17 April 2023
Cody N, Green A, McDevitt T, Lynch SA (2008) Cascade screening in BRCA1/2 mutation carriers. Ir Med J 101(5):140–142
pubmed: 18624259
Copson E, McVeigh T, Frost A, Tatton-Brown K (2022) GeNotes: a new online ‘just in time’ genomics resource for healthcare professionals. Future Healthc J 9(2):68–69. https://doi.org/10.7861/fhj.9-2-s68
doi: 10.7861/fhj.9-2-s68
pubmed: 36310986
pmcid: 9601014
European Union (2021). Eurostat. https://ec.europa.eu/eurostat/web/products-eurostat-news/-/ddn-20210224-1 Accessed 17 April 2023
Eysenbach G (2004) Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 6(3):e34. https://doi.org/10.2196/jmir.6.3.e34 Erratum in: https://doi.org/10.2196/jmir.2042
doi: 10.2196/jmir.6.3.e34
pubmed: 15471760
pmcid: 1550605
Grupe DW, Nitschke JB (2013) Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci 14(7):488–501. https://doi.org/10.1038/nrn3524
doi: 10.1038/nrn3524
pubmed: 23783199
pmcid: 4276319
Health Service Executive (2019) Model of care for rare diseases. https://www.lenus.ie/handle/10147/626904 . Accessed 17 Apr 2023
Health Service Executive (2022) National strategy for accelerating genetic and genomic medicine in Ireland. In: National Strategy for Accelerating Genetic and Genomic Medicine in Ireland (hseie) Accessed 17 April 2023
Lynch SA, Borg I (2016) Wide disparity of clinical genetics services and EU rare disease research funding across Europe. J Community Genet 7(2):119–126. https://doi.org/10.1007/s12687-015-0256-y
doi: 10.1007/s12687-015-0256-y
pubmed: 26536881
Makhnoon S, Shirts BH, Bowen DJ (2019) Patients’ perspectives of variants of uncertain significance and strategies for uncertainty management. J Genet Couns 28(2):313–325. https://doi.org/10.1002/jgc4.1075
doi: 10.1002/jgc4.1075
pubmed: 30636062
Malgorzata M, Maria S, Michał W (2022) Genetic testing-whether to allow complete freedom? Direct to consumer tests versus genetic tests for medical purposes. J Appl Genet 63(1):119–126. https://doi.org/10.1007/s13353-021-00670-z
doi: 10.1007/s13353-021-00670-z
pubmed: 34826052
National Treatment Purchase Fund (2022). https://www.ntpf.ie/home/outpatient.htm . Accessed 17 Apr 2023
NHS England (2023) National Genomic Test Directory for Rare and Inherited Disease. www.england.nhs.uk/publication/national-genomic-test-directories . Accessed 17 Apr 2023
Pichini A, Bishop M (2022) A nationally agreed cross-professional competency framework to facilitate genomic testing. Genet Med 24(8):1743–1752. https://doi.org/10.1016/j.gim.2022.04.023
doi: 10.1016/j.gim.2022.04.023
pubmed: 35583551
Sanderson S, Hill M, Patch C, Searle B, Lewis C, Chitty L (2019) Delivering genome sequencing in clinical practice: an interview study with healthcare professionals involved in the 100 000 Genomes Project. BMJ Open 9:e029699. https://doi.org/10.1136/bmjopen-2019-029699
doi: 10.1136/bmjopen-2019-029699
pubmed: 31685495
pmcid: 6858183
Snape K, Wedderburn S, Barwell J (2019) The new genomic medicine service and implications for patients. Clin Med (Lond) 19(4):273–277. https://doi.org/10.7861/clinmedicine.19-4-27
doi: 10.7861/clinmedicine.19-4-27
pubmed: 31308102
Studwell CM, Kelley EG, Undiagnosed Diseases Network, Sinsheimer JS, Palmer CGS, LeBlanc K (2021) Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice. J Genet Couns 30(2):439–447. https://doi.org/10.1002/jgc4.1329
doi: 10.1002/jgc4.1329
pubmed: 33108040
Vears DF, Sénécal K, Borry P (2020) Genetic health professionals’ experiences returning results from diagnostic genomic sequencing to patients. J Genet Couns 29(5):807–815. https://doi.org/10.1002/jgc4.1209
doi: 10.1002/jgc4.1209
pubmed: 31856387
Walsh N, Malone L, Lynch SA (2022) Duplication of referral, a tsunami of paper: how much does it cost the Irish health services? Ir J Med Sci 191(6):2439–2444. https://doi.org/10.1007/s11845-021-02866-y
doi: 10.1007/s11845-021-02866-y
pubmed: 35001335
pmcid: 8743075
Wedderburn LR, Worth A, Bueser T, Compton C, Deshpande C, Fassihi H, Haque E, Izatt L, Josifova D, Mohammed S, Robert L, Rose S, Ruddy D, Sarkany R, Say G, Shaw AC, Wolejko A, Habib B, Burns G et al (2021) 100,000 genomes pilot on rare-disease diagnosis in health care - preliminary report. N Engl J Med 385(20):1868–1880. https://doi.org/10.1056/NEJMoa2035790
doi: 10.1056/NEJMoa2035790
pubmed: 34758253